Pirsidomine, a novel nitric oxide donor, suppresses ischemic arrhythmias in anesthetized pigs

Journal of Cardiovascular Pharmacology

Volumn 22, Issue , 1993, Pages S44-S50

  Wainwright, Cherry L ^a   Martorana, Piero A ^b  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b SANOFI   (France)

Author keywords

Arrhythmias; Myocardial ischemia; Nitric oxide donor; Pigs; Pirsidomine

Indexed keywords

NITRIC OXIDE; PIRSIDOMINE; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ANESTHESIA; ANIMAL EXPERIMENT; CHEMOLUMINESCENCE; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY HEMODYNAMICS; HEART ARRHYTHMIA; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART VENTRICLE FIBRILLATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE ADHERENCE; NONHUMAN; PRIORITY JOURNAL; SWINE; THROMBOCYTE AGGREGATION;

ANIMAL; ARRHYTHMIA; ELECTROCARDIOGRAPHY; FREE RADICALS; HEMODYNAMICS; INJECTIONS, INTRAVENOUS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; PLATELET AGGREGATION; SWINE; SYDNONES; VASODILATOR AGENTS;

EID: 0027441819     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/00005344-199306227-00009     Document Type: Article

References (31)

1. Palmer RM, Ferrige AG, Moneada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
2. Moneada S, Palmer RMJ, Higgs EA. The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension 1988;12:365-72.
3. Bassenge E. Antiplatelet effects of endothelium-derived relaxing factor and nitric oxide donors. Eur Heart J 1991;12(suppl E):12-5.
4. Wright LD, Mulsch A, Busse R, Osswald H. Generation of nitric oxide by human neutrophils. Am J Physiol 1989;160:813-9.
5. Keim M, Schrader J. Nitric oxide release from the isolated guinea pig heart. Eur J Pharmacol 1988;155:317-21.
6. Parent R, Pare R, Lavallee M. Contribution of nitric oxide to dilation of resistance coronary vessels in conscious dogs. Am J Physiol 1992;262:H10-6.
7. Coker SJ, Parratt JR. Prostacyclin-antiarrhythmic or arrhyth-mogenic? Comparison of the effects of intravenous and intra-coronary prostacyclin and ZK 36374 during coronary artery occlusion and reperfusion in anaesthetized greyhounds. J Cardiovasc Pharmacol 1983;5:557-67.
8. Wainwright CL, Parratt JR. An antiarrhythmic effect of adenosine during myocardial ischaemia and reperfusion. Eur J Pharmacol 1988;146:183-94.
9. Vegh A, Papp JG, Szekeres L, Parratt JR. The local intracoronary administration of methylene blue prevents the pronounced antiarrhythmic effect of ischaemic preconditioning. Br J Pharmacol 1992;107:910-1.
10. Bohn H. Schönafinger K. Oxygen and oxidation promote the release of nitric oxide from sydnonimines. J Cardiovasc Pharmacol 1989;14(suppl II):S6-12.
11. Martorana PA, Mogilev AM, Kettenbach B, Nitz R-E. Effect of molsidomine on spontaneous ventricular fibrillation following myocardial ischaemia and reperfusion in the dog. Adv Myocardiol 1983;4:606-13.
12. Russel-Smith NC, Flower RJ. Cardinal DC. Measuring platelet and leukocyte aggregation/adhesion in very small volumes of whole blood. J Pharm Meth 1981;6:315-33.
13. Demiryürek AT, Wainwright CL, Wadsworth RM, Kane KA. Characterization of free radical production by porcine leukocytes. Br J Pharmacol 1992;107:319P.
14. Cano J-P, Guillen J-C, Jouve R, Langlet F, Puddu P-E, Rolland P-H, Serradimigni A. Molsidomine prevents post-ischaemic ventricular fibrillation in dogs. Br J Pharmacol 1986;88:779-89.
15. 2-agonist, CGS21680, reduce arrhythmias and suppress white cell accumulation in the porcine ischaemic myocardium. Br J Pharmacol 1992;107:97P.
16. Bohn H, Martorana PA, Schönafinger K. Cardiovascular effects of the new nitric oxide donor, pirsidomine: haemodynamic profile and tolerance studies in anaesthetized and conscious dogs. Eur J Pharmacol 1992;220:71-8.
17. Gorge G, Schmidt T, Ito BR, Pantley GA, Svhaper W. Microvascular and collateral adaptation in swine hearts following progressive coronary artery stenosis. Basic Res Cardiol 1989;84:524-35.
18. Bohn H, Beyerle R, Martorana PA, Schönafinger K. CAS 936, a novel sydnonimine with direct vasodilating and nitric oxide-donating properties: effects on isolated blood vessels. J Cardiovasc Pharmacol 1991;18:522-7.
19. Shah AM, Lewis MJ, Henderson AH. Effects of 8-bromo-cyclic GMP on contraction and on inotropic response offerret cardiac muscle. J Mol Cell Cardiol 1991;23:55-64.
20. Fort S, Lewis MJ. Regulation of myocardial contractile performance by sodium nitroprusside in the isolated perfused heart of the ferret. Br J Pharmacol 1991;102:351P.
21. Radomski MW, Palmer RMJ, Moneada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;1:1057-8.
22. Furlong B, Henderson AH, Lewis MJ, Smith JA. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol 1987;90:687-92.
23. Coker SJ, Dean HG, Kane KA, Parratt JR. The effects of ICS 205-930, a 5-HT antagonist, on arrhythmias and catecholamine release during canine myocardial ischaemia and reperfusion. Eur J Pharmacol 1986;127:211-8.
24. Coker SJ, Parratt JR, Ledingham IMCA, Zeitlin LJ. Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias. Nature 1981;291:323-4.
25. Wainwright CL, Parratt JR. The effects of L 655240, a selective thromboxane and prostaglandin endoperoxide antagonist, on ischaemia and reperfusion-induced cardiac arrhythmias. J Cardiovasc Pharmacol 1988;12:264-71.
26. Parratt JR, Wainwright CL. Failure of allopurinol and a spin trapping agent N-t-butyl-α-phenyl nitrone to modify significantly ischaemic and reperfusion-induced arrhythmias. Br J Pharmacol 1987;91:49-59.
27. Mullane KM, Westlin W, Kraemer R. Activated neutrophils release mediators that may contribute to myocardial injury and dysfunction associated with ischaemia and reperfusion. Ann NY Acad Sci 1988;524:103-21.
28. Lucchesi BR. Myocardial ischaemia, reperfusion and free radical injury. Am J Cardiol 1990;65:114-23.
29. McCall TB, Whittle BJR, Boughton-Smith NK, Moneada S. Inhibition of FMLP-induced aggregation of rabbit neutrophils by nitric oxide. Br J Pharmacol 1988;95:517P.
30. Clancy RM, Leszczynsk-Piziak J, Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 1992;90:1116-21.
31. Ervens J, Seifert R. Molsidomine inhibits the chemoattractant-induced respiratory burst in human neutrophils via a NO-independent mechanism. Biochem Pharmacol 1992;44:637-44.